Back

Distinct EBV-Associated Phenotypes Due to a Novel Homozygous Missense Variant in CD27.

Yang, R.; Turunbedu, S. K.; Nandiwada, S.; Curry, C. V.; Elghetany, T. M.; Scull, B.; Geng, J.; Vargas-Hernandez, A.; Chinn, I. K.; Ochoa, S.; Allen, C. E.; Satter, L. F.

2026-01-15 immunology
10.64898/2026.01.15.698722 bioRxiv
Show abstract

Biallelic deficiencies of CD27 and its ligand CD70 underlie selective susceptibility to Epstein-Barr virus (EBV) infection and its acute and chronic complications, underscoring their non-redundant roles in anti-EBV immunity. To date, 16 pathogenic CD27 variants have been reported. Here, we describe three patients from two unrelated families, homozygous for a novel loss-of-function (LOF) CD27 variant, resulting in substitution of serine 70 with proline (S70P). All three patients presented with EBV viremia and lymphoproliferative disease, with variable immune dysregulation or recurrent otosinopulmonary infections. One patient developed EBV-associated Hodgkin lymphoma. Functional studies demonstrated that the S70P variant impaired surface expression of CD27 and abolished CD70 binding, rendering complete LOF. Together, S70P represents a novel pathogenic CD27 variant causing autosomal recessive (AR) CD27 deficiency, characterized by a unified susceptibility to EBV yet variable clinical manifestations, ranging from chronic viremia to malignancy.

Published in Journal of Human Immunity · not in our set (fewer than 10 published preprints to learn from) · training set

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.